Viewing Study NCT03309592


Ignite Creation Date: 2025-12-24 @ 3:43 PM
Ignite Modification Date: 2026-02-04 @ 3:53 AM
Study NCT ID: NCT03309592
Status: WITHDRAWN
Last Update Posted: 2018-12-07
First Post: 2017-06-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Combination Ambrisentan and Tadalafil in Patients With Portopulmonary Hypertension
Sponsor: Ochsner Health System
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Portopulmonary Hypertension View
None Pulmonary Hypertension View
None Cirrhosis, Liver View
Keywords: